PharmAthene (PIP) sinking, down 15.1% premarket, as the FDA says it's put the firm's SparVax...

|By:, SA News Editor

PharmAthene (PIP) sinking, down 15.1% premarket, as the FDA says it's put the firm's SparVax anthrax vaccine program on clinical hold. Details to come from the agency within 30 days, but no adverse effects have been reported as the trial hadn't yet begun.